Massimo Calafiore was appointed chief commercial officer, and Ryan Donahoe was appointed chief technology officer. Both will report to CEO J. Christopher Barry.
Mr. Calafiore will oversee product marketing, commercial and commercial enablement functions. Mr. Donahoe will lead spine research and development.
“This new structure puts in place leaders who have decades of spine and orthopedics experience to advance our near- and long-term strategy as we continue to globalize and scale our business,” Mr. Barry said.
